The global clinical next-generation sequencing (NGS) market, valued at USD 6.2 billion in 2024, is expected to reach USD 15.2 billion by 2032 with a ...

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalence and precision medicine advancements. Key trends ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

Lt. Col. M. Kelly Hourihan, director of the division’s Special Pathogens Clinical Diagnostic Laboratory, said the project successfully demonstrated the value of next-generation sequencing ...

QIAGEN expands NGS portfolio with launch of QIAseq xHYB Long Read Panels: Venlo, The Netherlands Thursday, July 24, 2025, 10:00 Hrs [IST] QIAGEN, a Netherlands-based holding compa ...

Uncovering gene expression patterns, spatial transcriptomics bridges molecular analysis and tissue morphology, advancing research in various biological fields.

In this interview, the team at n6 discusses their groundbreaking iconPCR thermocycler and its impact on laboratory automation ...

U.S. Sanger Sequencing Market to Hit USD 4.25 Billion by 2032 as Demand for Reliable Genetic Sequencing in Healthcare Intensifies.Austin, July 16, 2025 (GLOBE NEWSWIRE) -- Sanger Sequencing Market ...

The Philippine Genome Center (PGC)-Visayas underscored the contribution of ‘next-generation sequencing’ in the field of ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier to treat than others.A local father and grandfather was told he had ...

Relationship Between Mutation Profile Detected by Next-generation Sequencing and Histopathological Parameters in Lung Squamous Cell Carcinoma. Article Publication Date. 15-Apr-2025.